Metastatic Breast Cancer: Advances in Treatment and Management

PROGRAM P10078 • RELEASE DATE: FEBRUARY 4, 2011 • EXPIRATION DATE: FEBRUARY 4, 2012
ESTIMATED TIME TO COMPLETE: 1.0 HOUR • COMPLETE THE POSTTEST AT WWW.THEONCOLOGPHARMACIST.COM

Download PDF

Click here to complete the posttest and obtain a CE certificate online

STATEMENT OF NEED

Mounting evidence continues to underscore the importance of exercise during and after cancer treatment as a way to promote quality of life, improve function, and potentially reduce comorbidities. In the past 2 decades, it has become increasingly clear that exercise also plays a vital role in cancer prevention and control. Exercise may decrease the risk of many cancers; extend survival for breast and colon cancer survivors; and prevent, attenuate, treat, or rehabilitate many of the psychological and physiological challenges faced by survivors. Because many oncology nurses practice in a location that lacks formal oncology rehabilitation services, they may be the primary providers for exercise prescription. For these situations, nurses can introduce early exercise intervention and help patients’ exercise regimens progress as they traverse along the cancer continuum.

TARGET AUDIENCE

Advanced practice nurses, registered nurses, and other interested healthcare professionals, especially those caring for cancer patients

LEARNING OBJECTIVES

After completing this activity, the reader should be able to:

• Discuss the impact of metastatic breast cancer and key parameters for disease stratification
• Describe the role of prognostic/genetic markers and tumor histology in classifying breast cancer subtypes and predicting treatment response
• Review advances in the treatment of metastatic breast cancer, in cluding the role of endocrine therapy, chemotherapy, targeted therapy, and bisphosphonates, with emphasis on targeted therapies
• Examine effective patient-tailored treatment approaches, based on recent data and clinical practice guidelines

CONTINUING NURSING EDUCATION ACCREDITATION AND CONTACT HOURS STATEMENT

Medical Learning Institute, Inc. is approved by the California Board of Registered Nursing, Provider number 15106, for 1.5 Contact hour.

METHOD OF PARTICIPATION

1. Read the article in its entirety
2. Select "Click here to complete the posttest and obtain a CE certificate online"
3. Complete and submit the CE posttest and CE Activity Evaluation
4. Print your Certificate of Credit This activity is provided free of charge to participants

This activity is provided free of charge to participants.

FACULTY DISClOSURES

Before the activity, all faculty will disclose the existence of any financial interest and/or relationship( s) they might have with the manufacturer( s) of any commercial products(s) to be discussed during their presentation(s): honoraria, expenses, grants, consulting roles, speakers’ bureau membership, stock ownership, or other special relationships. Pre - senters will inform participants of any offlabel discussions. Peer reviewers—Jayshree Shah, RN, APN-C, MSN, BSN, BS, is on the speakers’ bureau for Bristol-Myers Squibb, Celgene, Merck, and Novartis, and is on the advisory board for Bristol-Myers Squibb and Novartis. Nancy Nesser, JD, PharmD, has nothing to disclose.

• Joanna Schwartz, PharmD, BCOP, has nothing to disclose.
• Georgia Litsas, MSN, ANP-BC, AOCNP, is on the speakers’ bureau for Genentech, Novartis, and Pfizer.

The associates of Medical Learning Institute, Inc., the accredited provider for this activity, and Center of Excellence Media, LLC, do not have any financial relationships or relationships to products or devices with any commercial interest related to the content of this CE activity for any amount during the past 12 months.

DISClAIMER
The opinions and recommendations expressed by faculty, authors, and other experts whose input is included in this program are their own and do not necessarily represent the viewpoint of Medical Learning Institute, Inc. or Green Hill Healthcare Communications, LLC.

COPYRIGHT STATEMENT
Copyright © 2011 Medical Learning Institute, Inc. All rights reserved